Teva Pharmaceuticals' (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results
Categories
Health Care
Tivity Health, Inc. (NASDAQ: TVTY) Q1 2020 Earnings Call Transcript
Tivity Health, Inc. (TVTY) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Bob Greczyn -- Interim Chief Executive Officer Steve Janicak -- President of
CVS Health (NYSE: CVS) Q1 2020 Earnings Call Transcript
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q1 2020 Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo -- Head of Investor Relations Ludwig Hantson -- Chief Executive
Infographic: CVS Health Corporation (CVS) Q1 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported first quarter 2020 earnings results today. Total revenues increased 8.3% to $66.8 billion,driven mainly by strong
Alexion Pharmaceuticals (ALXN) Q1 profit drops 5% but beats estimates
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens.
Alexion (ALXN) to acquire Portola (PTLA) for $1.44 billion
Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an initial consideration
Regeneron Pharmaceuticals (REGN) Q1 profit jumps 36%, beats estimates
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The
Varian Medical Systems Inc (NYSE: VAR) Q2 2020 Earnings Call Transcript
Varian Medical Systems Inc (VAR) Q2 2020 earnings call dated May 04, 2020 Corporate Participants: Anshul Maheshwari -- Vice President, Treasury and Investor Relations
COVID-19 favors AbbVie (ABBV) in reporting upbeat Q1 results
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results
ImmunoGen CEO Mark Enyedy speaks on product strategy, pipeline and more
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
PetMed Express Inc (NASDAQ: PETS) Q4 2019 Earnings Call Transcript
PetMed Express Inc (PETS) Q4 2019 earnings call dated May. 04, 2020 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer Menderes
Novartis International AG (NYSE: NVS) Q1 2020 Earnings Call Transcript
Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the
Viking Therapeutics Inc (NASDAQ: VKTX) Q1 2020 Earnings Call Transcript
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz -- Manager, Investor Relations Brian Lian -- President and Chief
Baxter International Inc (NYSE: BAX) Q1 2020 Earnings Call Transcript
Baxter International Inc (BAX) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Clare Trachtman -- Vice President, Investor Relations Jose E. Almeida -- Chairman,
AbbVie Inc (NYSE: ABBV) Q1 2020 Earnings Call Transcript
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
ImmunoGen Inc. (NASDAQ: IMGN) Q1 2020 Earnings Call Transcript
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor Relations
Cigna Corp. (NYSE: CI) Q1 2020 Earnings Call Transcript
Cigna Corp. (CI) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: William McDowell -- Vice President of Investor Relations David M. Cordani -- President,
A visual dashboard of AbbVie’s Q1 2020 earnings results
AbbVie (NYSE: ABBV) reported its first quarter 2020 earnings results, which surpassed the market's views. Adjusted EPS of $2.42 and revenue of
Amgen Inc (NASDAQ: AMGN) Q1 2020 Earnings Call Transcript
Amgen Inc (AMGN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman